AVEO Pharmaceuticals (AVEO)

Create an Alert
2.62 -0.03  -1.13%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD

AVEO Pharmaceuticals News

CRL for AVEO/ALPMY's Tivozanib - Analyst Blog
Zacks Jun 12

AVEO Pharmaceuticals, Inc. and Astellas Pharma, Inc. received a complete response letter for tivozanib from the US FDA.

Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
Business Wire Jun 12

The Law Offices of Todd M. Garber announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of a class comprising all purchasers of the securities of AVEO Pharmaceuticals, Inc.

Drug Rejected! Let's Rejoice?
Fool Jun 11

AVEO's shares go up on the FDA's rejection of tivozanib.

AVEO Pharmaceuticals, Inc. - Special Call
Seeking Alpha Jun 11

AVEO Pharmaceuticals, Inc. - Special Call

AVEO Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma
Business Wire Jun 10

AVEO Oncology today announced that it has received a Complete Response letter from the U.S. Food and Drug Administration informing the company that the FDA wil

This Week in Biotech
Fool Jun 8

Clinical data, licensing, and layoffs -- oh, my!

AVEO Pharmaceuticals, Inc. - Special Call
Seeking Alpha Jun 5

AVEO Pharmaceuticals, Inc. - Special Call

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
AVEO 2.62 -0.03 -1.13% 136.46M
Create Watchlist from Quotes

Access watchlists and custom data alerts.
Start your free account.

Registering enables you to view unlimited pages per month.

required
required
required
required
Get Started Now

Already registered? Sign in here.

document.write('');